Jean-Marie Forel Selected Research

Neuromuscular Blocking Agents

12/2017	How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.
7/2017	Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
10/2012	The role of neuromuscular blockers in ARDS: benefits and risks.
9/2010	Neuromuscular blockers in early acute respiratory distress syndrome.
2/2009	Paralytics in critical care: not always the bad guy.
11/2006	Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome.
1/2004	Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Marie Forel Research Topics

Disease

21	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020 - 01/2004
12	Infections 05/2021 - 06/2009
11	Critical Illness (Critically Ill) 07/2021 - 01/2006
7	Septic Shock (Toxic Shock Syndrome) 01/2021 - 05/2005
6	Acute Kidney Injury (Acute Renal Failure) 04/2021 - 07/2016
6	Pneumonia (Pneumonitis) 01/2021 - 10/2010
5	Ventilator-Associated Pneumonia 05/2021 - 08/2012
5	Sepsis (Septicemia) 01/2021 - 05/2008
4	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 11/2010
4	Cross Infection (Nosocomial Infection) 01/2021 - 06/2009
4	Human Influenza (Influenza) 10/2020 - 10/2010
3	Hypoxia (Hypoxemia) 07/2021 - 02/2009
3	Oliguria 01/2021 - 07/2016
3	Acidosis 01/2021 - 07/2016
3	Body Weight (Weight, Body) 10/2018 - 01/2009
2	COVID-19 05/2021 - 02/2021
2	Kidney Diseases (Kidney Disease) 01/2021 - 07/2016
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 09/2007
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 01/2020
2	Thrombocytopenia (Thrombopenia) 10/2020 - 01/2020
2	Hyperkalemia 12/2019 - 07/2016
2	Pulmonary Edema 12/2019 - 07/2016
1	Obesity 07/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Meningitis 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Thrombosis (Thrombus) 10/2020
1	Venous Thromboembolism 10/2020
1	Pulmonary Embolism 10/2020
1	Bacterial Pneumonia 01/2020
1	Primary Graft Dysfunction 01/2020
1	Anuria 12/2019
1	Fibrosis (Cirrhosis) 03/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Coma (Comas) 01/2019
1	Peritonitis 01/2019
1	Shock 10/2018
1	Pressure Ulcer (Bedsore) 10/2018
1	Takotsubo Cardiomyopathy 01/2018
1	Reinfection 12/2017
1	Paralysis (Palsy) 07/2017
1	Renal Insufficiency (Renal Failure) 07/2016
1	Invasive Pulmonary Aspergillosis 11/2012
1	Right Ventricular Dysfunction 05/2012
1	Muscle Weakness 09/2010
1	Ventilator-Induced Lung Injury 09/2010

Drug/Important Bio-Agent (IBA)

7	Neuromuscular Blocking AgentsIBA 12/2017 - 01/2004
5	Oxygen (Dioxygen)IBA 07/2021 - 01/2006
3	Urea (Carbamide)FDA LinkGeneric 01/2021 - 07/2016
3	Biomarkers (Surrogate Marker)IBA 03/2019 - 05/2010
2	CatecholaminesIBA 04/2021 - 07/2016
2	NitrogenIBA 01/2021 - 07/2016
2	Biological ProductsIBA 01/2021 - 01/2011
2	procollagen Type III-N-terminal peptide (PIIP)IBA 03/2019 - 01/2015
2	AntibodiesIBA 01/2016 - 01/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015 - 06/2009
2	InterferonsIBA 12/2012 - 01/2012
2	ProcalcitoninIBA 10/2010 - 05/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2021
1	ruxolitinibIBA 02/2021
1	SteroidsIBA 01/2021
1	Prothrombin (Factor II)IBA 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 10/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	ProcollagenIBA 03/2019
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2019
1	Almitrine (Vectarion)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	CytokinesIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2013
1	galactomannanIBA 11/2012
1	AntigensIBA 11/2012
1	Pharmaceutical PreparationsIBA 10/2012
1	Type III Secretion SystemsIBA 08/2012
1	EpitopesIBA 08/2012
1	Immunoglobulin Fab FragmentsIBA 08/2012

Therapy/Procedure

13	Artificial Respiration (Mechanical Ventilation) 05/2021 - 05/2005
11	Therapeutics 01/2021 - 06/2009
6	Extracorporeal Membrane Oxygenation 10/2020 - 11/2010
5	Cannula 07/2021 - 11/2017
5	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 07/2016
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2010 - 01/2004
4	Mechanical Ventilators (Ventilator) 01/2016 - 09/2010
3	Catheters 04/2021 - 05/2008
2	Noninvasive Ventilation 07/2021 - 01/2019
2	Lung Transplantation 01/2018 - 12/2017
1	Central Venous Catheters 10/2020
1	Oxygenators 10/2020
1	Hand Hygiene 01/2020
1	Transplantation 01/2020
1	Artificial Kidneys 12/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Contraindications 01/2019
1	Length of Stay 10/2018
1	Anesthesia 01/2018
1	Salvage Therapy 11/2010